How many acquisitions has Emmes made so far?

Emmes has completed 7 acquisitions so far.

Which countries does Emmes usually acquire in?

Emmes has made acquisitions in 5 countries with the most activity in United States and United Kingdom.

List of 7 Acquisitions by Emmes (Sep 2026)

Q: Which is Emmes' latest acquisition?

Emmes's most recent acquisition is VaxTrials, a CRO specializing in managing and monitoring vaccine clinical trials, acquired in October 2023.

Emmes has made a total of 7 acquisitions. These 7 acquisitions were completed within 1 sector, Biopharma Outsourcing, across 5 countries, including United States, United Kingdom, and Germany. Peak activity occurred in 2021, 2022, and 2023, each recording 2 acquisitions. For the period between 2020 and 2025, the average number of acquisitions per year is 1.2, with 0 acquisitions completed in the current calendar year. The most recent acquisition is VaxTrials, a Panama-based CRO founded in 2012 that specializes in managing and monitoring vaccine clinical trials; this transaction took place in October 2023.

Here's the year on year acquisition history of Emmes:

Number of Total Acquisitions

Year	# Acquisitions
2023	2
2022	2
2021	2
2020	1

View all Acquisitions by Emmes

Recent acquisitions by Emmes

Emmes's most recent acquisition - VaxTrials is a CRO specializing in managing and monitoring vaccine clinical trials, founded in 2012 and located in Panama. Emmes acquired it in October 2023 for a price of $*****.

Here is the list of all acquisitions by Emmes sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Oct 05, 2023	VaxTrials	bn{u	rrkf	85	349
Mar 21, 2023	Essex Management	tbzq	gafv	14	821
Sep 28, 2022	Clinical Edge	obq{	euah	90	344
Mar 10, 2022	Casimir	qfln	wmnv	54	153
Dec 21, 2021	Institut Dr. Schauerte	llna	rfay	57	100

View the full list of acquisitions

View all Acquisitions by Emmes

Acquisitions by Emmes

List of Emmes's Acquisitions

Recent acquisitions by Emmes

FAQs about Acquisitions by Emmes